Cipla receives US FDA approval for generic Pulmicort Respules
The drug is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.